BE Healthcare Ventures
VC Fund
Taipei, Taiwan
BE Healthcare Ventures is a VC fund in Taipei focused on Health Care and Artificial Intelligence. BE Health Ventures is a boutique advisory and investment company, specializing in technologies, financials and healthcare industries.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 44%
Last updated:
For AI agents: llms.txt
Industries BE Healthcare Ventures invests in
Stages BE Healthcare Ventures invests in
Countries BE Healthcare Ventures invests in
Round sizes
Round size
- Seed
- $2.4M–$4.1M
Investment Focus
Industry
- Health Care 5 (56%)
- Artificial Intelligence 4 (44%)
- Medical 3 (33%)
- Software 3 (33%)
- Medical Device 3 (33%)
Stage
- Seed 5 (56%)
- Series A 1 (11%)
- Series B 1 (11%)
- Series C 1 (11%)
- Venture - Series Unknown 1 (11%)
Country
- Taiwan 6 (67%)
- Thailand 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
H2U
|
Health to U is a provider of digital health and wellbeing platform, focusing on holistic health, sports, and diets. The H2U Digital Health platform is a breakthrough creation, a framework that maximizes the power of data. The service delivers insightful reviews based on the platform’s analyses of data collected from connected products and services,elevating the overall value of each component. Users are able to get their hands on their records anytime at will, allowing them to stay aware and on top of their physiological states, with access to personalized health solutions and products. | $3.1M / Venture - Series Unknown / Mar 31, 2026 | |
AIM
|
AIM is a medical service provider that offers solutions to detect, diagnose, and monitor chronic bone and heart diseases in the elderly. | $4.1M / Seed / Sep 03, 2025 | |
Health2Sync
|
Health2Sync takes legacy medical devices and transforms your smartphone into a smart health monitoring machine; connecting users, loved ones, and clinicians. Our first product comes in the form of an app and accessory for smart blood glucose monitoring. | $20M / Series C / Mar 05, 2025 | |
Meticuly
|
Meticuly is a medical device company that specializes in AI-driven design and 3D-printed patient-specific titanium implants for cranial, maxillofacial, and orthopedic surgeries. Founded in 2017, the company leverages in-house developed AI engines and precision manufacturing to create custom implants tailored to individual patients, allowingMeticuly to achieve the fastest lead time in the industry. The company has served over 1,700 cases across more than 160 hospitals in Southeast Asia, the Middle East, and the UK. As the SEA market leader, Meticuly has expanded the flagship product families to the U.S. with two 510(k) clearances in 2022 and 2024. Meticuly holds 71 intellectual properties in its portfolio, globally applied across relevant markets. This achievement reflects its recognition as the 2024 WIPO Global Award winner from the World Intellectual Property Organization for innovation and intellectual property excellence, marking Meticuly as the first Thai startup to receive this honor. Meticuly complies with ISO 13485 and Medical Device Single Audit Program standards for quality management, reflecting its focus on enhancing clinical outcomes and patient care. Leveraging this foundational knowledge, Meticuly is now shaping the future of medical implants by deploying robust and scalable 3D printing at the point of care, marking a world-first milestone. | $4.2M / Series B / Jan 26, 2022 | |
dentall Co. Ltd.
|
Founded in 2016, dentall is a software company, also a leading dental solution provider in Taiwan, trusted by 8,000+ dentists across the nation. We focus on solving the pain points of digital integration in dentistry. The services include dentallHiS clinic management system, patient relations management, professional dental education and e-Commerceplatform. | $3.3M / Seed / Jan 18, 2022 | |
|
Meticuly
|
Meticuly is a medical device company that specializes in AI-driven design and 3D-printed patient-specific titanium implants for cranial, maxillofacial, and orthopedic surgeries. Founded in 2017, the company leverages in-house developed AI engines and precision manufacturing to create custom implants tailored to individual patients, allowingMeticuly to achieve the fastest lead time in the industry. The company has served over 1,700 cases across more than 160 hospitals in Southeast Asia, the Middle East, and the UK. As the SEA market leader, Meticuly has expanded the flagship product families to the U.S. with two 510(k) clearances in 2022 and 2024. Meticuly holds 71 intellectual properties in its portfolio, globally applied across relevant markets. This achievement reflects its recognition as the 2024 WIPO Global Award winner from the World Intellectual Property Organization for innovation and intellectual property excellence, marking Meticuly as the first Thai startup to receive this honor. Meticuly complies with ISO 13485 and Medical Device Single Audit Program standards for quality management, reflecting its focus on enhancing clinical outcomes and patient care. Leveraging this foundational knowledge, Meticuly is now shaping the future of medical implants by deploying robust and scalable 3D printing at the point of care, marking a world-first milestone. | $4.2M / Series A / Jul 01, 2021 | |
Neurobit
|
Neurobit creates and manufactures a complete neuro-otological diagnostic system. It offers video-oculography services for neurological disorders in the emergency department and day-care center. It is founded in 2016 and is based in Taipei City, Taiwan. | Seed / Mar 29, 2021 | |
Iweecare
|
Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable. | $2.4M / Seed / Sep 30, 2020 | |
Deep01 Technology
|
Certified with the U.S FDA, Deep01 develops an AI software that helps physicians accurately interpret computerized tomography (CT) images of the brain. DeepCT cover the symptoms include brain bleeding (ICH), brain pressure (midline shift), and skull fracture, generate over 95% of the accuracy within 30 seconds. Followed by, DeepCT received CE,PMDA, and TFDA. | $2.7M / Seed / Jun 22, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does BE Healthcare Ventures invest in?
BE Healthcare Ventures invests primarily in Health Care, Artificial Intelligence and Medical startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in Taiwan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is BE Healthcare Ventures's check size?
BE Healthcare Ventures typically joins rounds of $2.4M–$4.1M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds BE Healthcare Ventures participates in.
When did BE Healthcare Ventures last invest?
The most recent investment recorded for BE Healthcare Ventures closed in Mar 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
